New Program Aims to Improve Patient Medication AdherenceAllbiopro2018-07-12T14:48:46+09:007월 12th, 2018|
Vertex chief, thwarted by NICE, pressures England’s PM to play ball on drug pricesAllbiopro2018-07-11T08:42:16+09:007월 11th, 2018|
Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel DiseaseAllbiopro2018-07-11T08:41:49+09:007월 11th, 2018|
US FDA Approves Adagene IO program IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 trialAllbiopro2018-07-11T08:41:19+09:007월 11th, 2018|
Trump blasts Pfizer price hikes, pledges a governmental responseAllbiopro2018-07-11T08:40:52+09:007월 11th, 2018|
Torque’s T cell ‘backpacks’ boost immune attack against solid tumors in miceAllbiopro2018-07-11T08:40:27+09:007월 11th, 2018|
Therapy First, Efficiency Second: Why We Should Stop Focusing on Manufacturing CostsAllbiopro2018-07-11T08:40:02+09:007월 11th, 2018|
Takeda Receives Clearance from the United States Federal Trade Commission for the Proposed Acquisition of Shire plcAllbiopro2018-07-11T08:39:36+09:007월 11th, 2018|
Syntimmune picks up Vertex VP for CMO as leadership changes continueAllbiopro2018-07-11T08:39:09+09:007월 11th, 2018|
ProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-oncology Contract Development and Manufacturing ProjectAllbiopro2018-07-11T08:38:44+09:007월 11th, 2018|
Pharma’s digital ad spending is growing—but slowly, research saysAllbiopro2018-07-11T08:38:16+09:007월 11th, 2018|
PathoQuest Announces New Appointments to Executive Leadership TeamAllbiopro2018-07-11T08:37:51+09:007월 11th, 2018|
New targets found to reduce blood vessel damage in diabetesAllbiopro2018-07-11T08:37:26+09:007월 11th, 2018|
Mylan decimates the list price of its Copaxone copy. But why?Allbiopro2018-07-11T08:37:01+09:007월 11th, 2018|
Immune system reveals new ways to treat brain disease and painAllbiopro2018-07-11T08:36:36+09:007월 11th, 2018|
